KASINGER JAMES R. - Insider Non-Derivative Transactions at CRISPR Therapeutics AG (CRSP) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 12, 2024, KASINGER JAMES R.'s relationship to CRISPR Therapeutics AG (CRSP) is Officer (General Counsel and Secretary), and currently has 61,174 shares of Common Shares.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CRSP insiders.

Data Source: SEC.
KASINGER JAMES R. - Insider Non-Derivative Transactions of CRSP Common Shares
KASINGER JAMES R. - Insider Non-Derivative Transactions at CRSP
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 13, 2024 Sell -- (Common Shares) 1146 74.44 61174
Mar 12, 2024 Sell -- (Common Shares) 2801 78.26 60070
Mar 12, 2024 M -- (Common Shares) 2250 0 62320
Mar 11, 2024 M -- (Common Shares) 5500 0 62871
Feb 21, 2024 Sell -- (Common Shares) 1913 79.67 57371
Feb 19, 2024 M -- (Common Shares) 3825 0 59284
Mar 14, 2023 F -- (Common Shares) 1283 43.22 53616
Mar 14, 2023 F -- (Common Shares) 1022 43.22 54844
Mar 12, 2023 M -- (Common Shares) 2250 0 55866
Mar 11, 2023 M -- (Common Shares) 2833 0 54899
Feb 22, 2023 F -- (Common Shares) 1950 48.26 52066
Feb 19, 2023 M -- (Common Shares) 3825 0 54016